ArticleFrontiers in public health2026
Pricing decisions of converted and expanded enterprises for medical supplies under major public health emergencies.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Major public health emergencies often trigger severe imbalances between the supply and demand of medical supplies, resulting in substantial price fluctuations and reduced allocation efficiency. The rapid entry of converted and capacity-expanding enterprises into medical supply production further complicates pricing dynamics, particularly under government intervention policies. Methods: To investigate optimal pricing decisions under emergency conditions, this study integrates an epidemiological SEIR framework with an economic decision model and develops a Stackelberg game involving converted and expanded manufacturers under government subsidy schemes. Pricing strategies are compared under decentralized competitive and centralized cooperative scenarios to evaluate differences in market outcomes and welfare performance. Results: The data suggest that decentralized competition among businesses results in inflated prices and diminished efficiency in resource allocation. Conversely, collaborative pricing and resource integration demonstrably enhance firm profitability and contribute to greater overall social welfare. Furthermore, when production costs rise for manufacturers that have undergone conversion, the adverse impacts of cost escalation can be mitigated through the redistribution of demand among enterprises. Conclusion: This research furnishes a theoretical basis for pricing strategies concerning medical supplies during significant public health crises. The findings offer practical guidance for policymakers in the formulation of effective subsidy mechanisms and price regulation policies, thereby fortifying emergency medical supply systems. This study provides a theoretical foundation for pricing strategies of medical supplies during major public health emergencies. The results offer practical insights for policymakers in designing effective subsidy mechanisms and price regulation policies, thereby strengthening emergency medical supply.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.